Arax Advisory Partners’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $36.5M | Buy |
303,856
+9,927
| +3% | +$1.15M | 1.03% | 16 |
|
|
2025
Q4 | $30.9M | Sell |
293,929
-135,358
| -32% | -$12.7M | 0.9% | 25 |
|
|
2025
Q3 | $36M | Buy |
429,287
+146,145
| +52% | +$12M | 0.52% | 25 |
|
|
2025
Q2 | $22.4M | Buy |
283,142
+270,881
| +2,209% | +$21.5M | 1.03% | 26 |
|
|
2025
Q1 | $1.1M | Buy |
12,261
+5,676
| +86% | +$530K | 0.07% | 169 |
|
|
2024
Q4 | $655K | Buy |
6,585
+180
| +3% | +$18.6K | 0.04% | 236 |
|
|
2024
Q3 | $727K | Buy |
6,405
+257
| +4% | +$30.5K | 0.07% | 149 |
|
|
2024
Q2 | $761K | Buy |
6,148
+885
| +17% | +$114K | 0.07% | 136 |
|
|
2024
Q1 | $694K | Buy |
5,263
+226
| +4% | +$27.9K | 0.07% | 136 |
|
|
2023
Q4 | $549K | Buy |
5,037
+81
| +2% | +$8.41K | 0.06% | 135 |
|
|
2023
Q3 | $510K | Sell |
4,956
-113
| -2% | -$12.2K | 0.06% | 135 |
|
|
2023
Q2 | $585K | Buy |
5,069
+82
| +2% | +$9.31K | 0.07% | 104 |
|
|
2023
Q1 | $531K | Sell |
4,987
-18
| -0.4% | -$1.94K | 0.07% | 111 |
|
|
2022
Q4 | $555K | Buy |
5,005
+435
| +10% | +$44.5K | 0.08% | 101 |
|
|
2022
Q3 | $394K | Sell |
4,570
-435
| -9% | -$38.8K | 0.06% | 108 |
|
|
2022
Q2 | $456K | Buy |
5,005
+629
| +14% | +$55.8K | 0.07% | 100 |
|
|
2022
Q1 | $359K | Sell |
4,376
-475
| -10% | -$37.5K | 0.05% | 154 |
|
|
2021
Q4 | $372K | Buy |
4,851
+4
| +0.1% | +$319 | 0.05% | 155 |
|
|
2021
Q3 | $364K | Buy |
4,847
+1,045
| +27% | +$79.5K | 0.05% | 138 |
|
|
2021
Q2 | $296K | Buy |
+3,802
| New | +$283K | 0.04% | 182 |
|
|
2020
Q4 | $260K | Buy |
3,326
+113
| +4% | +$8.64K | 0.04% | 169 |
|
|
2020
Q3 | $254K | Sell |
3,213
-1,739
| -35% | -$136K | 0.04% | 142 |
|
|
2020
Q2 | $365K | Buy |
4,952
+5
| +0.1% | +$376 | 0.07% | 94 |
|
|
2020
Q1 | $363K | Buy |
4,947
+183
| +4% | +$14.4K | 0.08% | 89 |
|
|
2019
Q4 | $413K | Sell |
4,764
-130
| -3% | -$10.7K | 0.12% | 77 |
|
|
2019
Q3 | $393K | Buy |
4,894
+3
| +0.1% | +$240 | 0.12% | 78 |
|
|
2019
Q2 | $391K | Buy |
+4,891
| New | +$374K | 0.13% | 76 |
|
|
2018
Q4 | $312K | Buy |
4,286
+1,465
| +52% | +$103K | 0.12% | 86 |
|
|
2018
Q3 | $191K | Buy |
2,821
+565
| +25% | +$36K | 0.08% | 123 |
|
|
2018
Q2 | $130K | Buy |
2,256
+178
| +9% | +$10K | 0.06% | 131 |
|
|
2018
Q1 | $108K | Buy |
2,078
+1,404
| +208% | +$75.8K | 0.06% | 129 |
|
|
2017
Q4 | $36K | Sell |
674
-842
| -56% | -$46.7K | 0.02% | 239 |
|
|
2017
Q3 | $92K | Sell |
1,516
-529
| -26% | -$32.1K | 0.04% | 152 |
|
|
2017
Q2 | $121K | Buy |
2,045
+537
| +36% | +$32.7K | 0.06% | 138 |
|
|
2017
Q1 | $91K | Buy |
1,508
+641
| +74% | +$38.9K | 0.04% | 138 |
|
|
2016
Q4 | $49K | Buy |
+867
| New | +$50.7K | 0.02% | 168 |
|
Other funds holding MRK
VCM
VPM
Arax Advisory Partners's MRK Position: Q1 2026 in Review
Arax Advisory Partners increased its Merck (MRK) stake by 3.4% in Q1 2026, buying an estimated $1.15M and bringing the position to 303,856 shares worth $36.5M. The position accounts for 1.03% of the portfolio, ranked #16.
Arax Advisory Partners first reported a position in MRK in Q4 2016 and has held it in 36 quarters since. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.
- Arax Advisory Partners held 303,856 shares of Merck worth $36.5M as of Q1 2026.
- Arax Advisory Partners bought 9,927 Merck shares in Q1 2026, an estimated $1.15M.
- Merck made up 1.03% of Arax Advisory Partners's portfolio in Q1 2026, its #16 holding.
- Arax Advisory Partners first reported a position in Merck in Q4 2016 and has held it in 36 quarters since.
- 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.
Based on Arax Advisory Partners's 13F filing for Q1 2026, filed 13 May 2026.